Experimental, cancer-induced retinopathy.
Thirkill
C E
CE
University of California, Sacramento 95816, USA. cethirkill@ucdavis.edu
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D001323:Autoantibodies / Q000096:biosynthesis / Q000276:immunology*; D015153:Blotting, Western; D002135:Calcium-Binding Proteins / Q000276:immunology*; D018288:Carcinoma, Small Cell / Q000276:immunology*; D003930:Diabetic Retinopathy / Q000209:etiology / Q000473:pathology; D004195:Disease Models, Animal; D005136:Eye Proteins; D019084:Fluorescent Antibody Technique, Indirect; D006168:Guinea Pigs; D051597:Hippocalcin; D006801:Humans; D008074:Lipoproteins; D008175:Lung Neoplasms / Q000276:immunology*; D008253:Macaca mulatta; D008268:Macular Degeneration / Q000209:etiology / Q000473:pathology; D009419:Nerve Tissue Proteins; D010257:Paraneoplastic Syndromes / Q000209:etiology* / Q000473:pathology; D051603:Recoverin; D012160:Retina / Q000276:immunology / Q000473:pathology; D012174:Retinitis Pigmentosa / Q000209:etiology / Q000473:pathology; D014407:Tumor Cells, Cultured
D000951:Antigens, Neoplasm; D001323:Autoantibodies; D002135:Calcium-Binding Proteins; D005136:Eye Proteins; D008074:Lipoproteins; D009419:Nerve Tissue Proteins; C496731:RCVRN protein, human; D051603:Recoverin; D051597:Hippocalcin